Mode
Text Size
Log in / Sign up
N/A Completed N=31 Randomized Double-blind Prevention

NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy

Source: ClinicalTrials.gov NCT02107300 ↗
Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Dec 2018
Primary outcomePrimary: Change in Percentage of Time With CPAP (Continuous Positive Airway Pressure) Usage — -5.09; 11.67 percentage of time

Summary

To assess whether the daily use of NeutraSal will prevent or reduce dry mouth in patients undergoing CPAP therapy for OSAS and improve CPAP compliance

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Percentage of Time With CPAP (Continuous Positive Airway Pressure) Usage
-5.09; 11.67
SECONDARY
Mean Rate of Dry Mouth as Assessed by Xerostomia Questionnaire
.61; .73

Eligibility Criteria

Inclusion Criteria

  • Patient should be above 18 years of age.
  • Patients who have been initiated on CPAP therapy after an initial diagnosis of OSAS and have developed dry mouth or have worsening of pre-existing dry mouth condition, as an effect of CPAP therapy.
  • Ability to attend visits at the research site
  • Patient should be able to read and/or understand and sign the consent form be willing to participate in the research study

Exclusion Criteria

  • Patients with open mouth sores at study entry.
  • Any pathology that, based on the judgement of the researcher, could negatively affect the oral mucosa and subsequent treatment for xerostomia (immune disorders, etc.)
  • Patients using any other prophylactic mouthwashes.
  • Patients who are pregnant and/or nursing.
  • Patients becoming pregnant during the treatment period will be removed from data.
  • Patients on a low sodium diet
  • Patients currently on medication or treatment for xerostomia
  • Patients < 18 years of age
  • Hypersensitivity to any of the following ingredients- sodium chloride, sodium phosphate, calcium chloride and sodium bicarbonate
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02107300). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search